Page 33 - Christiana Care Focus June July 2018

| Extraordinary People
Gene Editing Institute receives innovation award from Philadelphia-Israeli Chamber of Commerce
FOCUS • JUNE–JULY 2018 31
For ground-breaking scientific research in gene editing and an innovative partnership with Jerusalem-based NovellusDx to advance personalized cancer treatment, the Gene Editing Institute of the Helen F. Graham Cancer Center & Research Institute at Christiana Care in May received the inaugural Life Sciences and Bio Innovation
TAward from the Philadelphia-Israeli Chamber of Commerce.
he new award was created to Institute is undertaking transformative recognize a company, researcher research in the human genome with direct or individual in the Tri-State applications to cancer care. By forming area that has the potential to partnerships with leading biomedical
make a significant impact on health care, firms around the world, the Gene Editing
From left, Eric Kmiec, Ph.D., director of the Gene Editing Institute of the Helen F. Graham Cancer Center & Research Institute at Christiana Care; Janice E. Nevin, M.D., MPH, Christiana Care president and CEO; Vered Nohi, executive director, Philadelphia-Israel Chamber of Commerce; Haim Gil-Ad, CEO of NovellusDx; Nicholas J. Petrelli, M.D., Bank of America endowed medical director of the Helen F. Graham Cancer Center & Research Institute; Lois Galinat, chair of the Friends of the Helen F. Graham Cancer Center & Research Institute; Carroll M. Carpenter, former chair of Christiana Care Trustees; and Gordon Brownlee, vice president of Development at Christiana Care.
according to the Philadelphia-Israeli Chamber of Commerce.
“We are building the tools of tomorrow
as we provide leading-edge care for our patients today,” said Janice E. Nevin, M.D., MPH,ChristianaCarepresidentand
chief executive officer. “The Gene Editing
Institute is laying the groundwork for a vibrant, job-producing innovation corridor in Delaware and the region.”
A unique strength of the Gene Editing Institute is its integration within the Helen F.GrahamCancerCenter. CONTINUED